CEL-SCI Co. (NYSEAMERICAN:CVM) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 526,760 shares, an increase of 14.0% from the November 30th total of 462,000 shares. Approximately 4.8% of the shares of the company are short sold. Based on an average daily trading volume, of 128,714 shares, the days-to-cover ratio is currently 4.1 days.

In related news, Director Vicente Benjamin Asuncion sold 160,000 shares of the stock in a transaction that occurred on Tuesday, October 17th. The shares were sold at an average price of $0.39, for a total value of $62,400.00.

Separately, Dawson James reaffirmed a “neutral” rating on shares of CEL-SCI in a research note on Monday, October 16th.

Shares of CEL-SCI (CVM) opened at $1.89 on Monday. The company has a market cap of $22.24, a P/E ratio of -1.43 and a beta of -1.58. CEL-SCI has a one year low of $1.46 and a one year high of $4.50.

TRADEMARK VIOLATION NOTICE: “CEL-SCI Co. (CVM) Sees Significant Growth in Short Interest” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.watchlistnews.com/cel-sci-co-cvm-sees-significant-growth-in-short-interest/1790163.html.

About CEL-SCI

CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.

Receive News & Ratings for CEL-SCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI and related companies with MarketBeat.com's FREE daily email newsletter.